CONTROLLED TRIAL OF CLINICAL UTILITY OF SERUM SALICYLATE MONITORING IN RHEUMATOID-ARTHRITIS
- 1 January 1984
- journal article
- research article
- Vol. 11 (4), 457-461
Abstract
A crossover double-blind controlled trial was performed on 36 patients with rheumatoid arthritis to assess the necessity for serum salicylate monitoring in determining optimal dosage. There was no clinically or statistically significant increase in the clinical improvement of patients associated with serum monitoring but potentially toxic serum levels occurred without tinnitus when serum monitoring was not used.This publication has 4 references indexed in Scilit:
- Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin TherapyAnnals of Internal Medicine, 1979
- INDEPENDENT ASSESSOR AND POOLED INDEX AS TECHNIQUES FOR MEASURING TREATMENT EFFECTS IN RHEUMATOID-ARTHRITIS1977
- Salicylate Therapy in Rheumatoid ArthritisJAMA, 1965
- Rapid determination of salicylate in biological fluidsBiochemical Journal, 1954